Quantbot Technologies LP Ani Pharmaceuticals Inc Transaction History

Quantbot Technologies LP

$3.55 Billion
Q2 2025

A detailed history of Quantbot Technologies LP transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Quantbot Technologies LP holds 8,045 shares of ANIP stock, worth $765,240. This represents 0.01% of its overall portfolio holdings.

Number of Shares

8,045

Previous 19,585 58.92%

Holding current value

$765,240

Previous $1.31 Million 60.03%

% of portfolio

0.01%

Previous 0.05%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$57.79 - $72.95 $666,896 - $841,843	-11,540 Reduced 58.92%	8,045 $524,000
Q1 2025 May 13, 2025	BUY	$53.93 - $68.36 $1.06 Million - $1.34 Million	19,585 New	19,585 $1.31 Million
Q1 2024 May 06, 2024	BUY	$54.2 - $69.69 $38,969 - $50,107	719 New	719 $49,000
Q3 2023 Nov 07, 2023	SELL	$50.28 - $64.61 $187,544 - $240,995	-3,730 Reduced 74.35%	1,287 $74,000
Q2 2023 Aug 08, 2023	BUY	$37.29 - $53.83 $144,275 - $208,268	3,869 Added 337.02%	5,017 $270,000
Q1 2023 May 12, 2023	BUY	$37.61 - $45.72 $43,176 - $52,486	1,148 New	1,148 $45,000
Q2 2022 Aug 09, 2022	SELL	$23.09 - $33.46 $20,781 - $30,114	-900 Reduced 39.13%	1,400 $41,000
Q1 2022 May 16, 2022	BUY	$26.91 - $47.15 $61,893 - $108,445	2,300 New	2,300 $64,000
Q4 2019 Feb 10, 2020	SELL	$55.65 - $79.83 $21,981 - $31,532	-395 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$64.7 - $85.39 $19,086 - $25,190	295 Added 295.0%	395 $28,000
Q2 2019 Aug 13, 2019	BUY	$67.77 - $82.2 $6,777 - $8,220	100 New	100 $8,000

Others Institutions Holding ANIP

# of Institutions

247

Shares Held

20M

Call Options Held

19.9K

Put Options Held

12.8K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.66B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.

Account

Quantbot Technologies LP Ani Pharmaceuticals Inc Transaction History